Oruka Therapeutics’ (ORKA) Outperform Rating Reiterated at Wedbush
Wedbush reissued their outperform rating on shares of Oruka Therapeutics (NASDAQ:ORKA – Free Report) in a report published on Friday morning,RTT News reports. The brokerage currently has a $40.00 price objective on the stock. Several other equities analysts have also commented on the stock. HC Wainwright reaffirmed a “buy” rating and issued a $45.00 price […]
Wedbush reissued their outperform rating on shares of Oruka Therapeutics (NASDAQ:ORKA – Free Report) in a report published on Friday morning,RTT News reports. The brokerage currently has a $40.00 price objective on the stock. Several other equities analysts have also commented on the stock. HC Wainwright reaffirmed a “buy” rating and issued a $45.00 price […]
